Market Live: Sensex off opening high, Nifty breaks 10,100; Infosys, Biocon rally News News / News 6 years ago 589 Views comments Biocon surged 10 percent as the US FDA approved Mylan and Biocon#39;s Ogivri, the first biosimilar for Trastuzumab, for the Treatment of HER2-Positive... Read more
News Market Update: Bank Nifty outperforms as Nifty inches towards record high; ICICI Bank, BOI up 2% News / News - 6 years ago
News Rajiv Gandhi case convict Perarivalan gets ordinary leave, to walk out of prison after 26 years News / News - 6 years ago
News Buy Aurobindo Pharma, Welspun India; sell Britannia Industries: Ashwani Gujral News / News - 6 years ago
Comments